Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry

Abstract Introduction Similar outcomes have been observed between patients with rheumatoid arthritis (RA) responding to tocilizumab (TCZ) with methotrexate (MTX) who discontinued vs. continued MTX and between patients receiving MTX who added TCZ vs. switched to TCZ monotherapy. This study examined M...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Dimitrios A. Pappas, Taylor Blachley, Steve Zlotnick, Jennie Best, Kelechi Emeanuru, Joel M. Kremer
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Adis, Springer Healthcare 2020-03-01
Sarja:	Rheumatology and Therapy
Aiheet:	Methotrexate Registry Rheumatoid arthritis Tocilizumab
Linkit:	https://doi.org/10.1007/s40744-020-00200-z
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!